Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048792949> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W3048792949 endingPage "8" @default.
- W3048792949 startingPage "1" @default.
- W3048792949 abstract "Background: There are many misconceptions about conducting research with Schedule 1 (CI) controlled substances to conduct nonclinical research in the US. Research design cannot be driven by financial constraints. Aim: The notion that current regulatory control of CI drugs hamper, hinders, or restricts legitimate nonclinical research in the U.S. may reflect a lack of understanding of the procedures in place to study these drugs. Review: Nonclinical research must comply with the Good Laboratory Practice (GLP) guidelines (21 CFR §58) of the U.S. Food & Drug Administration (FDA). Protocol development under the GLPs provides the information and details required under the Controlled Substances Act (CSA) for submission to the two drug regulating agencies relevant to the approvals required prior to the first dose administration on the study. Under 21 USC § 823(f), the registration applications by practitioners wishing to conduct Schedule I research shall be referred by the Secretary of HHS (FDA), who shall determine the qualifications and competency of each practitioner, as well as the merits of the research protocol. Additionally, a formal verification of the professional standards of the Study Director and the research facility conducting the study will be conducted by the DEA. These additional two requirements differentiate studies conducted with CI drugs and all other schedule-controlled drugs. In the U.S., the security requirements for storage under current DEA administrative regulations are equivalent for both CI and CII drugs. Conclusion: An informed researcher conducting nonclinical studies with CII– CV drugs can easily comply with current drug control requirements to conduct research with CI drugs in the US." @default.
- W3048792949 created "2020-08-18" @default.
- W3048792949 creator A5025129912 @default.
- W3048792949 date "2020-01-01" @default.
- W3048792949 modified "2023-09-23" @default.
- W3048792949 title "Schedule I Control Status Does Not Impede Legitimate Nonclinical Research" @default.
- W3048792949 hasPublicationYear "2020" @default.
- W3048792949 type Work @default.
- W3048792949 sameAs 3048792949 @default.
- W3048792949 citedByCount "0" @default.
- W3048792949 crossrefType "journal-article" @default.
- W3048792949 hasAuthorship W3048792949A5025129912 @default.
- W3048792949 hasConcept C111919701 @default.
- W3048792949 hasConcept C112930515 @default.
- W3048792949 hasConcept C142724271 @default.
- W3048792949 hasConcept C144024400 @default.
- W3048792949 hasConcept C144133560 @default.
- W3048792949 hasConcept C154945302 @default.
- W3048792949 hasConcept C17744445 @default.
- W3048792949 hasConcept C204787440 @default.
- W3048792949 hasConcept C2775924081 @default.
- W3048792949 hasConcept C2779318504 @default.
- W3048792949 hasConcept C2780385302 @default.
- W3048792949 hasConcept C3018890749 @default.
- W3048792949 hasConcept C36289849 @default.
- W3048792949 hasConcept C39549134 @default.
- W3048792949 hasConcept C41008148 @default.
- W3048792949 hasConcept C509550671 @default.
- W3048792949 hasConcept C68387754 @default.
- W3048792949 hasConcept C71924100 @default.
- W3048792949 hasConceptScore W3048792949C111919701 @default.
- W3048792949 hasConceptScore W3048792949C112930515 @default.
- W3048792949 hasConceptScore W3048792949C142724271 @default.
- W3048792949 hasConceptScore W3048792949C144024400 @default.
- W3048792949 hasConceptScore W3048792949C144133560 @default.
- W3048792949 hasConceptScore W3048792949C154945302 @default.
- W3048792949 hasConceptScore W3048792949C17744445 @default.
- W3048792949 hasConceptScore W3048792949C204787440 @default.
- W3048792949 hasConceptScore W3048792949C2775924081 @default.
- W3048792949 hasConceptScore W3048792949C2779318504 @default.
- W3048792949 hasConceptScore W3048792949C2780385302 @default.
- W3048792949 hasConceptScore W3048792949C3018890749 @default.
- W3048792949 hasConceptScore W3048792949C36289849 @default.
- W3048792949 hasConceptScore W3048792949C39549134 @default.
- W3048792949 hasConceptScore W3048792949C41008148 @default.
- W3048792949 hasConceptScore W3048792949C509550671 @default.
- W3048792949 hasConceptScore W3048792949C68387754 @default.
- W3048792949 hasConceptScore W3048792949C71924100 @default.
- W3048792949 hasIssue "2" @default.
- W3048792949 hasLocation W30487929491 @default.
- W3048792949 hasOpenAccess W3048792949 @default.
- W3048792949 hasPrimaryLocation W30487929491 @default.
- W3048792949 hasRelatedWork W1123516428 @default.
- W3048792949 hasRelatedWork W1883414044 @default.
- W3048792949 hasRelatedWork W201064510 @default.
- W3048792949 hasRelatedWork W2031089246 @default.
- W3048792949 hasRelatedWork W2044511815 @default.
- W3048792949 hasRelatedWork W2055662005 @default.
- W3048792949 hasRelatedWork W2127996309 @default.
- W3048792949 hasRelatedWork W2130817039 @default.
- W3048792949 hasRelatedWork W2133598582 @default.
- W3048792949 hasRelatedWork W2165431340 @default.
- W3048792949 hasRelatedWork W2189014650 @default.
- W3048792949 hasRelatedWork W2331958953 @default.
- W3048792949 hasRelatedWork W2595193106 @default.
- W3048792949 hasRelatedWork W2598397289 @default.
- W3048792949 hasRelatedWork W3012556905 @default.
- W3048792949 hasRelatedWork W73435793 @default.
- W3048792949 hasRelatedWork W90663901 @default.
- W3048792949 hasRelatedWork W1697040715 @default.
- W3048792949 hasRelatedWork W2117388489 @default.
- W3048792949 hasRelatedWork W2344244646 @default.
- W3048792949 hasVolume "9" @default.
- W3048792949 isParatext "false" @default.
- W3048792949 isRetracted "false" @default.
- W3048792949 magId "3048792949" @default.
- W3048792949 workType "article" @default.